Chitosan as a bone scaffold biomaterial

Steven D. Kozusko, Charles Riccio, Micheline Goulart, Joel Bumgardner, Xi Lin Jing, Petros Konofaos

Research output: Contribution to journalArticle

Abstract

The current standard of care for bone reconstruction, whether secondary to injury, nonunion, cancer resection, or idiopathic bone loss, is autologous bone grafting. Alternatives to autograft and allograft bone substitutes currently being researched are synthetic and natural graft materials that are able to guide bone regeneration. One promising material currently being researched is chitosan, a highly versatile, naturally occurring polysaccharide, derived from the exoskeleton of arthropods that is comprised of glucosamine and N-acetylglucosamine. Research on chitosan as a bone scaffold has been promising. Chitosan is efficacious in bone regeneration due to its lack of immunogenicity, its biodegradability, and its physiologic features. Chitosan combined with growth factors and/or other scaffold materials has proven to be an effective alternative to autologous bone grafts. Additionally, current studies have shown that it can provide the additional benefit of a local drug delivery system. As research in the area of bone scaffolding continues to grow, further clinical research on chitosan in conjunction with growth factors, proteins, and alloplastic materials will likely be at the forefront.

Original languageEnglish (US)
Pages (from-to)1788-1793
Number of pages6
JournalJournal of Craniofacial Surgery
Volume29
Issue number7
DOIs
StatePublished - Jan 1 2018

Fingerprint

Chitosan
Biocompatible Materials
Bone and Bones
Bone Regeneration
Intercellular Signaling Peptides and Proteins
Research
Transplants
Bone Substitutes
Bone Transplantation
Acetylglucosamine
Arthropods
Glucosamine
Autografts
Drug Delivery Systems
Standard of Care
Allografts
Polysaccharides
Wounds and Injuries
Neoplasms
Proteins

All Science Journal Classification (ASJC) codes

  • Surgery
  • Otorhinolaryngology

Cite this

Chitosan as a bone scaffold biomaterial. / Kozusko, Steven D.; Riccio, Charles; Goulart, Micheline; Bumgardner, Joel; Jing, Xi Lin; Konofaos, Petros.

In: Journal of Craniofacial Surgery, Vol. 29, No. 7, 01.01.2018, p. 1788-1793.

Research output: Contribution to journalArticle

Kozusko, SD, Riccio, C, Goulart, M, Bumgardner, J, Jing, XL & Konofaos, P 2018, 'Chitosan as a bone scaffold biomaterial', Journal of Craniofacial Surgery, vol. 29, no. 7, pp. 1788-1793. https://doi.org/10.1097/SCS.0000000000004909
Kozusko, Steven D. ; Riccio, Charles ; Goulart, Micheline ; Bumgardner, Joel ; Jing, Xi Lin ; Konofaos, Petros. / Chitosan as a bone scaffold biomaterial. In: Journal of Craniofacial Surgery. 2018 ; Vol. 29, No. 7. pp. 1788-1793.
@article{26a6a474708c4449bbe4d86e7ea3152f,
title = "Chitosan as a bone scaffold biomaterial",
abstract = "The current standard of care for bone reconstruction, whether secondary to injury, nonunion, cancer resection, or idiopathic bone loss, is autologous bone grafting. Alternatives to autograft and allograft bone substitutes currently being researched are synthetic and natural graft materials that are able to guide bone regeneration. One promising material currently being researched is chitosan, a highly versatile, naturally occurring polysaccharide, derived from the exoskeleton of arthropods that is comprised of glucosamine and N-acetylglucosamine. Research on chitosan as a bone scaffold has been promising. Chitosan is efficacious in bone regeneration due to its lack of immunogenicity, its biodegradability, and its physiologic features. Chitosan combined with growth factors and/or other scaffold materials has proven to be an effective alternative to autologous bone grafts. Additionally, current studies have shown that it can provide the additional benefit of a local drug delivery system. As research in the area of bone scaffolding continues to grow, further clinical research on chitosan in conjunction with growth factors, proteins, and alloplastic materials will likely be at the forefront.",
author = "Kozusko, {Steven D.} and Charles Riccio and Micheline Goulart and Joel Bumgardner and Jing, {Xi Lin} and Petros Konofaos",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/SCS.0000000000004909",
language = "English (US)",
volume = "29",
pages = "1788--1793",
journal = "Journal of Craniofacial Surgery",
issn = "1049-2275",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Chitosan as a bone scaffold biomaterial

AU - Kozusko, Steven D.

AU - Riccio, Charles

AU - Goulart, Micheline

AU - Bumgardner, Joel

AU - Jing, Xi Lin

AU - Konofaos, Petros

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The current standard of care for bone reconstruction, whether secondary to injury, nonunion, cancer resection, or idiopathic bone loss, is autologous bone grafting. Alternatives to autograft and allograft bone substitutes currently being researched are synthetic and natural graft materials that are able to guide bone regeneration. One promising material currently being researched is chitosan, a highly versatile, naturally occurring polysaccharide, derived from the exoskeleton of arthropods that is comprised of glucosamine and N-acetylglucosamine. Research on chitosan as a bone scaffold has been promising. Chitosan is efficacious in bone regeneration due to its lack of immunogenicity, its biodegradability, and its physiologic features. Chitosan combined with growth factors and/or other scaffold materials has proven to be an effective alternative to autologous bone grafts. Additionally, current studies have shown that it can provide the additional benefit of a local drug delivery system. As research in the area of bone scaffolding continues to grow, further clinical research on chitosan in conjunction with growth factors, proteins, and alloplastic materials will likely be at the forefront.

AB - The current standard of care for bone reconstruction, whether secondary to injury, nonunion, cancer resection, or idiopathic bone loss, is autologous bone grafting. Alternatives to autograft and allograft bone substitutes currently being researched are synthetic and natural graft materials that are able to guide bone regeneration. One promising material currently being researched is chitosan, a highly versatile, naturally occurring polysaccharide, derived from the exoskeleton of arthropods that is comprised of glucosamine and N-acetylglucosamine. Research on chitosan as a bone scaffold has been promising. Chitosan is efficacious in bone regeneration due to its lack of immunogenicity, its biodegradability, and its physiologic features. Chitosan combined with growth factors and/or other scaffold materials has proven to be an effective alternative to autologous bone grafts. Additionally, current studies have shown that it can provide the additional benefit of a local drug delivery system. As research in the area of bone scaffolding continues to grow, further clinical research on chitosan in conjunction with growth factors, proteins, and alloplastic materials will likely be at the forefront.

UR - http://www.scopus.com/inward/record.url?scp=85054437473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054437473&partnerID=8YFLogxK

U2 - 10.1097/SCS.0000000000004909

DO - 10.1097/SCS.0000000000004909

M3 - Article

VL - 29

SP - 1788

EP - 1793

JO - Journal of Craniofacial Surgery

JF - Journal of Craniofacial Surgery

SN - 1049-2275

IS - 7

ER -